These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1473854)

  • 1. Comparison of bioavailability and pharmacodynamics of diltiazem from two pharmaceutical preparations.
    Dange SV; Nandal DH; Gokhale VS; Shah KU; Kadam DB
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):205-8. PubMed ID: 1473854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
    Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker.
    Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
    De Bernardis E; Candido P; Lorefice R; Picari M; Rizza V
    Arzneimittelforschung; 1992 Jan; 42(1):25-7. PubMed ID: 1586376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of diltiazem administered once and twice daily.
    Mooser V; Waeber B; Nussberger J; Brunner HR
    J Hum Hypertens; 1988 Dec; 2(4):257-60. PubMed ID: 3236328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
    Luckow V; Della Paschoa O
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and pharmacodynamics of diltiazem floating tablets].
    Gu TH; Chen SX; Zhu JB; Song DJ; Guo JZ; Hou HM
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):527-31. PubMed ID: 1302441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
    Christensen H; Asberg A; Holmboe AB; Berg KJ
    Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diltiazem bioavailability from 3 marketed extended-release products for once-daily administration: implications of chronopharmacokinetics and dynamics.
    Eradiri O; Midha KK
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):369-73. PubMed ID: 9314089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
    Sigusch H; Henschel L; Kraul H; Merkel U; Hoffmann A
    Pharmazie; 1994 Sep; 49(9):675-9. PubMed ID: 7972311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem on PR intervals in healthy young adults.
    Araki H; Hotokebuchi N; Ohta T; Sakaino N; Nishi K
    Clin Ther; 1986; 8(2):196-202. PubMed ID: 3698067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
    Turner SW; Jungbluth GL; Knuth DW
    Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.